Search

Your search keyword '"A-C. Su"' showing total 226 results

Search Constraints

Start Over You searched for: Author "A-C. Su" Remove constraint Author: "A-C. Su" Topic medicine.medical_specialty Remove constraint Topic: medicine.medical_specialty
226 results on '"A-C. Su"'

Search Results

1. A Double-Blind, Placebo-Controlled, Crossover Study of Magnesium Supplementation in Patients with XMEN Disease

2. Impact of Low-Dose Computed Tomography Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis

3. Total and free vitamin D metabolites in patients with primary hyperparathyroidism

4. A Rare Case of Cutaneous Mucoepidermoid Carcinoma of the Eyelid: A Case Report and Literature Review

5. A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)Capsule Summary

6. Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)

7. Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab

8. Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic—Consensus: Recommendations by an international panel of experts

9. The Growing Spectrum of Human Diseases Caused by InheritedCDC42 Mutations

10. Pre-treatment quality of life as a predictor of distant metastasis-free survival and overall survival in patients with head and neck cancer who underwent free flap reconstruction

11. Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion

12. The Ever-Increasing Array of Novel Inborn Errors of Immunity: an Interim Update by the IUIS Committee

14. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

15. Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation

16. Exome sequencing study in a clinical research setting finds general acceptance of study returning secondary genomic findings with little decisional conflict

17. Endoscopic thulium laser ablation of upper tract urothelial carcinoma: A retrospective study with subgroup analyses

18. Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?

19. Prevention of atopic dermatitis: Etiological considerations and identification of potential strategies

20. Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti–Vascular Endothelial Growth Factor Injections

21. Retrospective review of screening for Sturge-Weber syndrome with brain magnetic resonance imaging and electroencephalography in infants with high-risk port-wine stains

22. Skin Cancer Following Solid Organ Transplantation: A Review of Risk Factors and Models of Care

23. Efficacy And Safety Of Crisaborole In Patients Aged 3 Months To 17 Years With Mild-To-Moderate Atopic Dermatitis

24. 27582 Abrocitinib improves work productivity through improvement in pruritus and sleep: Results from the JADE MONO-2 study in patients with moderate-to-severe atopic dermatitis (AD)

25. Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome

26. Multi-level obstruction in obstructive sleep apnoea: prevalence, severity and predictive factors

27. Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide

28. Age at onset and persistence of eczema are related to subsequent risk of asthma and hay fever from birth to 18 years of age

29. A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients

30. 299MO Efficacy and safety of entrectinib in an Asian population with NTRK fusion-positive (fp) solid tumours or ROS1-fp NSCLC

31. Haploinsufficiency of immune checkpoint receptor CTLA4 induces a distinct neuroinflammatory disorder

32. Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD)

33. Artificial Intelligence in Dermatology-Where We Are and the Way to the Future: A Review

34. 157 A comparison study of Outcome Measures for Epidermolysis Bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)

35. FP14.11 Icotinib versus Chemotherapy as Adjuvant Treatment for Stage II–IIIA EGFR-Mutant NSCLC (EVIDENCE): A Randomized, Open-Label, Phase 3 Study

36. Pruritus, Sleep, and Productivity: A Post Hoc Analysis of Abrocitinib Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD) From JADE MONO-2

37. The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa

38. 16018 Safety, efficacy, and pharmacokinetics of crisaborole ointment, 2%, in infants aged 3 to < 24 months with mild to moderate atopic dermatitis

39. Assessment of diagnostic biomarkers of liver injury in the setting of microcystin-LR (MC-LR) hepatotoxicity

41. Position Statement on Atopic Dermatitis in Sub-Saharan Africa: current status and roadmap

42. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME)

43. Evaluation of Recipients of Positive and Negative Secondary Findings Evaluations in a Hybrid CLIA-Research Sequencing Pilot

44. The impact of conversion on the risk of major complication following laparoscopic colonic surgery: an international, multicentre prospective audit

47. Transferring 100,000 Samples of Risk Group 3 Biological Agents in Singapore—Lessons Learned

48. Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis

49. Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice

50. Cdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology

Catalog

Books, media, physical & digital resources